US Patent Issued to RaQualia Pharma on Jan. 13 for "Method for selecting cancer patients for whom combination therapy with retinoid and cancer therapeutic agent is effective, and combination medicament with retinoid and cancer therapeutic agent" (Japanese Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,358, issued on Jan. 13, was assigned to RaQualia Pharma Inc. (Aichi, Japan).

"Method for selecting cancer patients for whom combination therapy with retinoid and cancer therapeutic agent is effective, and combination medicament with retinoid and cancer therapeutic agent" was invented by Tadashi Iida (Aichi, Japan), Atsushi Enomoto (Aichi, Japan), Yasuyuki Mizutani (Aichi, Japan), Masahide Takahashi (Aichi, Japan), Mitsuhiro Fujishiro (Aichi, Japan), Hiroki Kawashima (Aichi, Japan), Yoshihisa Matsukawa (Aichi, Japan) and Takayuki Owaki (Aichi, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method for selecting a...